Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
Int J Health Policy Manag
.
2019 Oct 1;8(10):627-628.
doi: 10.15171/ijhpm.2019.60.
Authors
Yurie Kobashi
1
2
,
Makoto Watanabe
3
,
Hideaki Kimura
3
,
Asaka Higuchi
1
,
Akihiko Ozaki
1
4
Affiliations
1
Medical Governance Research Institute, Tokyo, Japan.
2
Department of Anesthesia, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan.
3
Waseda Chronicle, Tokyo, Japan.
4
Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan.
PMID:
31657193
PMCID:
PMC6819628
DOI:
10.15171/ijhpm.2019.60
No abstract available
Publication types
Letter
MeSH terms
Conflict of Interest / economics*
Databases as Topic
Disclosure
Drug Industry / economics*
Humans
Japan
Physicians / economics*